Comorbidity of panic disorder and major depressive disorder: effects on platelet alpha 2 adrenergic receptors.
Adrenergic receptor dysregulation has been described as occurring in both major depressive disorder (MDD) and panic disorder. Measurements of platelet alpha 2 adrenergic receptors in these patients may be confounded by the coexistence or comorbidity of both diagnoses in the same patient. To explore this possibility, we measured platelet alpha 2 adrenergic receptors (3H-clonidine and 3H-yohimbine binding) in 3 groups of patients (MDD only, panic disorder only, and those showing comorbidity of MDD and panic) and normal controls. Patients with comorbidity of MDD and panic disorder had significantly lower agonist binding (3H-clonidine).
Grunhaus
L J
LJ
Department of Psychiatry, University of Michigan Medical Center, Ann Arbor 48109-0118.
Cameron
O
O
Pande
A C
AC
Haskett
R F
RF
Hollingsworth
P J
PJ
Smith
C B
CB
D000328:Adult; D001008:Anxiety Disorders / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology*; D001667:Binding, Competitive / Q000502:physiology; D001792:Blood Platelets / Q000502:physiology*; D003000:Clonidine / Q000493:pharmacokinetics*; D003866:Depressive Disorder / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology*; D005239:Fear / Q000502:physiology*; D005260:Female; D006801:Humans; D008297:Male; D010200:Panic / Q000502:physiology*; D011569:Psychiatric Status Rating Scales; D011941:Receptors, Adrenergic / Q000502:physiology*; D015016:Yohimbine / Q000493:pharmacokinetics*
D011941:Receptors, Adrenergic; D015016:Yohimbine; D003000:Clonidine